论文信息 - Prevalence and treatment of anti-NMDA receptor encephalitis - 字舞流文

Prevalence and treatment of anti-NMDA receptor encephalitis

A. Šedivá | V. Komarek | Z. Liba | V. Sebroňová | P. Sedláček

[1] L. Honig,et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study , 2013, The Lancet Neurology.

[2] M. Fritzler,et al. Anti-NMDA receptor encephalitis. The disorder, the diagnosis and the immunobiology. , 2012, Autoimmunity reviews.

[3] R. Balice-Gordon,et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis , 2011, The Lancet Neurology.

[4] K. Selmaj,et al. Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity. , 2010, Brain : a journal of neurology.

[5] M. Rosenfeld,et al. Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma , 2009, Acta Neuropathologica.